Aura Biosciences, Inc. (AURA)
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Aura Biosciences, Inc.
NASDAQ:AURAHealthcare · Biotechnology
-2.46%$6.14
AH$6.14+0.00%vs close
Mkt Cap$636.75M
Float92.38M
O/S103.7M
Vol
$ Vol
RVOL
Inst Own92.2%
SI11.8%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$106.19M
Total Assets$169.43M
Free Cash Flow-$85.19M
Debt & Equity
Debt 11%
Equity 89%
Total Debt$17.38M
Total Equity$136.91M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in AURA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$169.43M
Liabilities$32.52M
Accounts Receivable$0
Accounts Payable$1.55M
Inventory$0
PP&E (Net)$18.45M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $1.29M | $0 | $0 | $0 | $509K |
| Gross Profit | $0 | $0 | -$1.29M | $0 | $0 | $0 | -$509K |
| Gross Margin | - | - | - | - | - | - | - |
| Research and Development | $90.3M | $73.3M | $63.94M | $42.24M | $25.16M | $18.04M | $19.11M |
| Selling, General, and Administrative | $22.49M | $22.81M | $19.76M | $18.06M | $10.09M | $4.16M | $4.52M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $112.79M | $96.12M | $83.7M | $60.3M | $35.25M | $22.21M | $23.63M |
| Operating Income (EBIT) | -$112.79M | -$96.12M | -$84.99M | -$60.3M | -$35.25M | -$22.21M | -$24.14M |
| Operating Margin | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $3K | $5K |
| Interest Income | $6.63M | $9.43M | $8.59M | $1.86M | $13K | $3 | $5 |
| Other Income (Expense) | $6.71M | $9.31M | $8.72M | $1.53M | -$1K | $0 | -$60K |
| Income Before Tax (EBT) | -$106.08M | -$86.81M | -$76.27M | -$58.76M | -$35.25M | -$22.21M | -$24.2M |
| Income Tax Expense | $108K | $112K | $137K | $0 | $0 | $0 | $0 |
| Net Income | -$106.19M | -$86.92M | -$76.41M | -$58.76M | -$35.25M | -$22.21M | -$24.2M |
| Net Income Margin | - | - | - | - | - | - | - |
| Supplementary Data | |||||||
| EPS | -1.76 | -1.75 | -1.93 | -1.96 | -1.58 | -1.03 | -0.01 |
| Diluted EPS | -1.76 | -1.75 | -1.93 | -1.96 | -1.58 | -1.03 | -0.01 |
| Weighted Average OS | 60.34M | 49.65M | 39.62M | 29.94M | 29.21M | 29.22M | 2.92B |
| EBITDA | -$104.95M | -$85.58M | -$74.98M | -$57.59M | -$34.41M | -$21.38M | -$23.69M |
| EBITDA Margin | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $59.52M | $31.69M | $41.06M | $121.58M | $149.06M | $17.39M | $32.47M |
| Short-Term Investments | $84.73M | $119.4M | $185.09M | $67.23M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $144.24M | $151.09M | $226.15M | $188.81M | $149.06M | $17.39M | $32.47M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.18M | $1.83M | $3.83M | $5.72M | $89K | $35K | $56K |
| Total Current Assets | $149.74M | $160.62M | $231.79M | $196.7M | $153.7M | $18.45M | $33.35M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $18.45M | $20.59M | $22M | $26.04M | $6.2M | $3.57M | $3.63M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $768K | $0 | $0 | $75K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $1.24M | $1.29M | $1.28M | $423K | $125K | $75K | $0 |
| Total Long-Term Assets | $19.69M | $21.88M | $23.28M | $27.23M | $6.33M | $3.65M | $3.71M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $169.43M | $182.5M | $255.07M | $223.94M | $160.03M | $22.1M | $37.05M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $1.55M | $2.3M | $1.79M | $2.92M | $2.4M | $611K | $2.33M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $15K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $6.25M | $618K | $935K | $3.03M | $2.65M | $1.28M | $2.52M |
| Total Current Liabilities | $18.38M | $14.91M | $12.36M | $10.46M | $7.36M | $2.66M | $6.15M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $14.13M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $80K | $95K |
| Total Long-Term Liabilities | $14.13M | $15.62M | $16.87M | $17.89M | $360K | $80K | $144K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $32.52M | $30.53M | $29.23M | $28.35M | $7.71M | $2.74M | $6.29M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $128.08M | $118.17M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$480.42M | -$374.23M | -$287.31M | -$210.9M | -$152.14M | -$116.89M | -$94.68M |
| Comprehensive Income & Other | -$102K | $263K | $539K | -$72K | $0 | $0 | $0 |
| Other Stockholders' Equity | $617.33M | $526.2M | $513.16M | $406.48M | $304.45M | $136.25M | $125.44M |
| Total Equity | $136.91M | $151.97M | $225.85M | $195.58M | $152.31M | $19.36M | $30.76M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $169.43M | $182.5M | $255.07M | $223.94M | $160.03M | $22.1M | $37.05M |
| Supplementary Data | |||||||
| Total Debt | $17.38M | $18.77M | $19.56M | $20.86M | $975K | $15K | $49K |
| Net Debt | -$42.14M | -$12.92M | -$21.51M | -$100.72M | -$148.09M | -$17.38M | -$32.42M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$106.19M | -$86.92M | -$76.41M | -$58.76M | -$35.25M | -$22.21M | -$24.2M |
| Depreciation & Amortization | $1.13M | $1.22M | $1.29M | $1.18M | $831K | $831K | $509K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $14K | $0 | $0 |
| Stock-Based Compensation | $14.32M | $11.72M | $8.77M | $6.41M | $2.31M | $736K | $507K |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$846K | $482K | -$1.04M | $340K | $1.05M | -$1.72M | $1.04M |
| Other Working Capital | $6.82M | -$3.12M | $5.48M | -$3.44M | -$1.37M | -$1.96M | $1.42M |
| Total Working Capital Change | $5.97M | -$2.64M | $4.44M | -$3.1M | -$315K | -$3.68M | $2.46M |
| Other Non-Cash Items | $32K | -$3.19M | -$1.95M | -$325K | $4K | -$3K | $54K |
| Net Cash from Operating | -$84.74M | -$79.81M | -$63.85M | -$54.6M | -$32.41M | -$24.32M | -$20.67M |
| Investing Activities | |||||||
| Capital Expenditures | -$447K | -$1.25M | -$709K | -$1.09M | -$2.13M | -$771K | -$2.22M |
| Acquisitions | $0 | $0 | $0 | $67K | $0 | $0 | $0 |
| Purchases of Investments | -$83.96M | -$59.11M | -$233.65M | -$119.78M | $0 | $0 | $0 |
| Sales of Investments | $120M | $129.18M | $120.4M | $53.01M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$67K | $0 | $0 | $0 |
| Net Cash from Investing | $35.59M | $68.82M | -$113.96M | -$67.87M | -$2.13M | -$771K | -$2.22M |
| Financing Activities | |||||||
| Debt Repaid | - | - | - | - | - | $34K | $37K |
| Common Stock Issuance | $77.16M | $1.59M | $3.17M | $8.55M | $78.7M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | -$13K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $1.5M | $430K | $334K | $163K | $57K |
| Net Cash from Financing | $77.16M | $1.59M | $97.29M | $95.63M | $166.26M | $10.04M | $39.73M |
| Forex Effect | -$186K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $27.82M | -$9.39M | -$80.52M | -$26.84M | $131.72M | -$15.06M | $16.84M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$84.74M | -$79.81M | -$63.85M | -$54.6M | -$32.41M | -$24.32M | -$20.67M |
| Capital Expenditure | -$447K | -$1.25M | -$709K | -$1.09M | -$2.13M | -$771K | -$2.22M |
| Free Cash Flow | -$85.19M | -$81.06M | -$64.56M | -$55.7M | -$34.53M | -$25.09M | -$22.89M |
| Cash at Beginning | $32.46M | $41.85M | $122.37M | $149.21M | $17.49M | $32.54M | $15.7M |
| Cash at End | $60.28M | $32.46M | $41.85M | $122.37M | $149.21M | $17.49M | $32.54M |